tiprankstipranks
Edesa Biotech Inc (EDSA)
NASDAQ:EDSA
Holding EDSA?
Track your performance easily

Edesa Biotech (EDSA) Income Statement

252 Followers

Edesa Biotech Income Statement

Last quarter (Q3 2024), Edesa Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Edesa Biotech's net income was $-1.67M. See Edesa Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
----$ 328.80K$ 410.87K
Cost of Revenue
----$ 17.60K$ 101.29K
Gross Profit
----$ 311.20K$ 309.58K
Operating Expense
$ 7.80M$ 8.64M$ 18.37M$ 13.34M$ 6.71M$ 3.14M
Operating Income
$ -7.80M$ -8.64M$ -18.37M$ -23.68M$ -6.40M$ -2.83M
Net Non Operating Interest Income Expense
$ 208.95K$ 289.85K$ 63.52K$ 11.16K$ 37.78K$ 56.84K
Other Income Expense
$ -697.57K$ -21.74K$ -780.26K$ -10.34M$ -366.00$ -1.44K
Pretax Income
$ -6.93M$ -8.37M$ -17.55M$ -13.34M$ -6.36M$ -2.78M
Tax Provision
$ 800.00$ 800.00$ 800.00$ -800.00$ 800.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.93M$ -8.37M$ -17.55M$ -13.34M$ -6.36M$ -2.78M
Basic EPS
$ -2.21$ -2.93$ -8.37$ -1.10$ -0.74$ -0.55
Diluted EPS
$ -2.21$ -2.93$ -8.37$ -1.10$ -0.74$ -0.55
Basic Average Shares
$ 12.57M$ 2.86M$ 2.10M$ 12.08M$ 8.61M$ 5.04M
Diluted Average Shares
$ 12.57M$ 2.86M$ 2.10M$ 12.08M$ 8.61M$ 5.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 7.80M$ 8.64M$ 18.37M$ -13.34M$ -6.73M$ 3.24M
Net Income From Continuing And Discontinued Operation
$ -6.93M$ -8.37M$ -17.55M$ -13.34M$ -6.36M$ -2.78M
Normalized Income
$ -6.42M$ -6.15M$ -12.90M$ -13.34M$ -4.68M$ -2.78M
Interest Expense
------
EBIT
$ -6.93M$ -8.37M$ -17.55M$ -13.34M$ -6.36M$ -2.83M
EBITDA
$ -6.74M$ -8.19M$ -17.43M$ -13.22M$ -6.31M$ -2.83M
Currency in USD

Edesa Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis